Allen Chiang MD
Retinal Disease
Retina Service of Wills Eye Hospital
Join to View Full Profile
4060 Butler PikeSte 200Plymouth Meeting, PA 19462
Phone+1 800-331-6634
Fax+1 267-420-1363
Dr. Chiang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Allen Chiang is an ophthalmologist based in Plymouth Meeting, PA, specializing in retinal diseases. He completed his medical education at New York University School of Medicine, followed by a residency in Ophthalmology at the Stein Eye Institute at UCLA, and a fellowship in Surgical Retina and Vitreous at Wills Eye Hospital. He is an Associate Clinical Professor at Thomas Jefferson University Hospital and a faculty member at Wills Eye Hospital and partner at Mid Atlantic Retina. His expertise includes diabetic retinopathy, macular degeneration, and macular edema, among others. Dr. Chiang has contributed to multiple publications on related topics and is involved in clinical trials for age-related macular degeneration and diabetic retinopathy. His accolades include being named a Top Doctor by Castle-Connolly and Philadelphia Magazine, and receiving awards from the AAO and ASRS.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalFellowship, Surgical Retina and Vitreous, 2009 - 2011
UCLA David Geffen School of Medicine/UCLA Medical Center/UCLA Stein and Doheny Eye InstitutesResidency, Ophthalmology, 2006 - 2009
Scripps Mercy HospitalInternship, Transitional Year, 2005 - 2006
New York University School of MedicineClass of 2005
Certifications & Licensure
PA State Medical License 2009 - 2026
DE State Medical License 2013 - 2025
NJ State Medical License 2013 - 2025
CA State Medical License 2006 - 2024
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctor Castle-Connolly, 2023-2025
- Top Doctor Philadelphia Magazine, 2023-2025
- Secretariat Award AAO, 2023
- Join now to see all
Clinical Trials
- Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) Start of enrollment: 2016 Mar 29
- A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration Start of enrollment: 2018 Aug 31
Publications & Presentations
PubMed
- 7 citationsConversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.Asad Farooq Durrani, Bita Momenaei, Taku Wakabayashi, Sudheshna Vemula, Saagar A Pandit
The British Journal of Ophthalmology. 2024-08-22 - 22 citationsClinical Outcomes of Faricimab in Patients with Previously Treated Neovascular Age-Related Macular Degeneration.Saagar A Pandit, Bita Momenaei, Taku Wakabayashi, Hana A Mansour, Sudheshna Vemula
Ophthalmology. Retina. 2024-04-01 - 1 citationsVITRECTOMY FOR VITREOUS HEMORRHAGE ASSOCIATED WITH RETINAL VEIN OCCLUSION: Visual Outcomes, Prognostic Factors, and Sequelae.Taku Wakabayashi, Neil Patel, Matthew Bough, Ankur Nahar, Young Sheng
Retina. 2023-09-01
Press Mentions
Apellis Presents Phase 3 Functional Analyses of SYFOVRE™ (Pegcetacoplan Injection) for Geographic AtrophyApril 23rd, 2023
Grant Support
- Innovation GrantWills Eye HospitalPresent
Committees
- Member, Wills Eye Hospital Peer Review
Professional Memberships
- Member
- Member
- Member
- The Retina SocietyMember
External Links
- Mid Atlantic Retinahttp://www.midatlanticretina.com
- Wills Eye Hospitalhttp://www.willseye.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
